Onderneming Olainfarm AS Nasdaq Riga
Aandelen
OLF1R
LV0000100501
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- LVL | - |
2021 | Transcript : AS Olainfarm, Q2 2021 Earnings Call, Aug 31, 2021 | |
2021 | Als Olainfarm de resultaten voor het halfjaar eindigend op 30 juni 2021 bekendmaakt | CI |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Juris Bundulis
CEO | Chief Executive Officer | 70 | 19-06-21 |
- | - | ||
Chief Tech/Sci/R&D Officer | - | 01-01-10 | |
Gita Silina
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-14 |
Chief Tech/Sci/R&D Officer | 45 | 12-06-17 | |
Chief Tech/Sci/R&D Officer | - | 01-01-06 | |
Genadijs Melnis
ADM | Chief Administrative Officer | - | 01-01-98 |
Corporate Officer/Principal | - | 05-06-18 | |
Janis Leimanis
IRC | Investor Relations Contact | 54 | 17-06-21 |
Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Janis Buks
CHM | Chairman | - | 30-07-21 |
Director/Board Member | - | 01-01-07 | |
Irina Maligina
BRD | Director/Board Member | 40 | 05-06-18 |
Director/Board Member | 61 | 19-06-21 | |
Vadims Telica
BRD | Director/Board Member | 60 | - |
Roberts Tavjevs
BRD | Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 14 085 078 | 3 330 721 ( 23,65 %) | 0 | 23,65 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+15,91% | 41,97 mld. | |
+22,40% | 22,34 mld. | |
+18,48% | 15,25 mld. | |
+16,12% | 14 mld. | |
+45,12% | 12,06 mld. | |
-0,05% | 6,79 mld. | |
-9,58% | 6,8 mld. | |
-8,87% | 5,73 mld. | |
+14,18% | 5,49 mld. |
- Beurs
- Aandelen
- Koers OLF1R
- Koers OLF1R
- Onderneming Olainfarm AS